Abecma 欧州連合 - アイスランド語 - EMA (European Medicines Agency)

abecma

bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - Æxlishemjandi lyf - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.

Serevent Innúðalyf, dreifa 25 míkróg/skammt アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

serevent innúðalyf, dreifa 25 míkróg/skammt

glaxosmithkline pharma a/s - salmeterolum xínafóat - innúðalyf, dreifa - 25 míkróg/skammt

Livopan Lyfjagas undir þrýstingi 50/50 % アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

livopan lyfjagas undir þrýstingi 50/50 %

linde sverige ab - dinitrogenii oxidum; oxygenium - lyfjagas undir þrýstingi - 50/50 %